In the past decade, bacteria‐based cancer immunotherapy has attracted much attention in
the academic circle due to its unique mechanism and abundant applications in triggering the …

Within the tumor microenvironment (TME), regulatory T cells (Tregs) play a key role in
suppressing anticancer immune responses; therefore, various strategies targeting Tregs are …

Following infection with Mycobacterium tuberculosis, the causative agent of tuberculosis
(TB), most human hosts are able to contain the infection and avoid progression to active TB …

The recognition of the curative potential of the graft‐versus‐leukaemia effect for patients with
acute myeloid leukaemia (AML) undergoing stem cell transplantation, and the emergence of …

Recent studies have provided several insights into acute myeloid leukemia. Studies based
on molecular biology have identified eight functional mutations involved in leukemogenesis …

In spite of progresses in the therapy of different malignancies, melanoma still remains as
one of lethal types of skin tumor. Melanoma is almost easily treatable by surgery alone with …

Introduction Triple-negative breast cancer (TNBC) is the most fatal molecular subtype of
breast cancer because of its aggressiveness and resistance to chemotherapy. FDA …

This book examines the crucial role of a unique alpha-fetoprotein (AFP) in the treatment of
cancer. AFP can deliver toxins through specific receptors re-expressed in the majority of …

Mycobacterium tuberculosis (Mtb) has remained one of the major infectious disease killers
for generations and generations. In 2023 alone, this ancient disease was responsible for the …

The epidermal growth factor receptor (EGFR) remains one of the best molecules for
developing targeted therapy for multiple human malignancies, including head and neck …